Premium
Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 ( Covid ‐19)
Author(s) -
Zhou Yue,
Chi Jingwei,
Lv Wenshan,
Wang Yangang
Publication year - 2021
Publication title -
diabetes/metabolism research and reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.307
H-Index - 110
eISSN - 1520-7560
pISSN - 1520-7552
DOI - 10.1002/dmrr.3377
Subject(s) - obesity , diabetes mellitus , covid-19 , outbreak , medicine , epidemiology , disease , coronavirus , environmental health , pandemic , intensive care medicine , infectious disease (medical specialty) , virology , endocrinology
The outbreak of the coronavirus disease 2019 (Covid‐19) has become an evolving worldwide health crisis. With the rising prevalence of obesity and diabetes has come an increasing awareness of their impacts on infectious diseases, including increased risk for various infections, post‐infection complications and mortality from critical infections. Although epidemiological and clinical characteristics of Covid‐19 have been constantly reported, no article has systematically illustrated the role of obesity and diabetes in Covid‐19, or how Covid‐19 affects obesity and diabetes, or special treatment in these at‐risk populations. Here, we present a synthesis of the recent advances in our understanding of the relationships between obesity, diabetes and Covid‐19 along with the underlying mechanisms, and provide special treatment guidance for these at‐risk populations.